HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yunping Luo Selected Research

XAV939

1/2021CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yunping Luo Research Topics

Disease

43Neoplasms (Cancer)
03/2024 - 05/2003
21Breast Neoplasms (Breast Cancer)
10/2023 - 07/2003
14Neoplasm Metastasis (Metastasis)
01/2021 - 07/2003
5Carcinoma (Carcinomatosis)
04/2008 - 05/2003
4Lung Neoplasms (Lung Cancer)
03/2024 - 04/2005
4Infections
02/2022 - 12/2006
4Inflammation (Inflammations)
01/2021 - 10/2015
2Communicable Diseases (Infectious Diseases)
02/2022 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
11/2016 - 06/2013
2Melanoma (Melanoma, Malignant)
04/2008 - 06/2004
1Head and Neck Neoplasms (Head and Neck Cancer)
05/2022
1Porcine Reproductive and Respiratory Syndrome (PRRS)
02/2022
1COVID-19
02/2022
1Carcinogenesis
01/2021
1Disease Progression
01/2020
1Lymphatic Metastasis
01/2019
1Hypersensitivity (Allergy)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2019
1Hepatitis
11/2015
1Psoriasis (Pustulosis Palmaris et Plantaris)
10/2015
1Necrosis
06/2009

Drug/Important Bio-Agent (IBA)

15VaccinesIBA
02/2022 - 05/2003
12DNA VaccinesIBA
09/2011 - 05/2003
7Small Interfering RNA (siRNA)IBA
01/2021 - 02/2013
6Proteins (Proteins, Gene)FDA Link
01/2019 - 12/2006
5asparaginylendopeptidase (legumain)IBA
12/2011 - 01/2006
4MicroRNAs (MicroRNA)IBA
01/2021 - 11/2016
4Transcription Factors (Transcription Factor)IBA
11/2014 - 07/2003
4LigandsIBA
12/2011 - 08/2005
4AutoantigensIBA
04/2008 - 06/2004
3Immune Checkpoint InhibitorsIBA
03/2024 - 01/2021
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2023 - 09/2005
3CateninsIBA
01/2021 - 11/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2015 - 08/2006
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2011 - 01/2006
3DNA (Deoxyribonucleic Acid)IBA
04/2008 - 05/2003
3A-Form DNA (A-DNA)IBA
04/2005 - 07/2003
2EnzymesIBA
03/2024 - 01/2021
2Toll-Like Receptors (Toll-Like Receptor)IBA
02/2022 - 02/2010
2Vaccine AdjuvantsIBA
02/2022 - 01/2019
2Cancer VaccinesIBA
01/2021 - 09/2011
2Cadherins (E-Cadherin)IBA
01/2021 - 11/2014
2Estrogen ReceptorsIBA
01/2021 - 01/2019
2CytokinesIBA
11/2020 - 12/2018
2Intercellular Adhesion Molecule-3IBA
08/2018 - 01/2018
2AntigensIBA
09/2011 - 04/2008
2Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2009 - 05/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2009 - 08/2006
2Peptide Hydrolases (Proteases)FDA Link
04/2008 - 01/2006
2SurvivinIBA
04/2006 - 01/2005
2Interleukin-18 (Interleukin 18)IBA
04/2005 - 07/2003
2fos-related antigen 1IBA
04/2005 - 07/2003
1Carnitine (L-Carnitine)FDA LinkGeneric
03/2024
1Fatty Acids (Saturated Fatty Acids)IBA
03/2024
1TransferasesIBA
03/2024
1Chimeric Antigen ReceptorsIBA
10/2023
1OligodeoxyribonucleotidesIBA
05/2022
1Toll-Like Receptor AgonistsIBA
02/2022
1XAV939IBA
01/2021
1AntibodiesIBA
01/2021
1Lactate Dehydrogenase 5IBA
01/2021
1statticIBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
11/2020
1AgarIBA
01/2020
1Cilostazol (Pletal)FDA LinkGeneric
01/2020
1Type 3 Cyclic Nucleotide PhosphodiesterasesIBA
01/2020
1Aldehyde DehydrogenaseIBA
01/2020
1Lactic Acid (Lactate)FDA LinkGeneric
01/2019
1Glucose (Dextrose)FDA LinkGeneric
01/2019
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
01/2019
1Cisplatin (Platino)FDA LinkGeneric
12/2018
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
12/2018
1AntagomirsIBA
12/2018
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
08/2018
1lifitegrastIBA
08/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Phenobarbital (Luminal)FDA Link
01/2017
1JNK Mitogen-Activated Protein KinasesIBA
11/2015
1GalactosamineIBA
11/2015
1LipopolysaccharidesIBA
11/2015
1Thiostrepton (Gargon)IBA
10/2015
1Imiquimod (Aldara)FDA LinkGeneric
10/2015
1I-kappa B KinaseIBA
04/2015
1Antineoplastic Agents (Antineoplastics)IBA
06/2014
1ErbB Receptors (EGF Receptor)IBA
02/2013
1Enzyme Inhibitors (Inhibitors, Enzyme)IBA
12/2011
11- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA
09/2011
1Beclin-1IBA
08/2011
1Interleukin-7 (Interleukin 7)IBA
11/2009
1Messenger RNA (mRNA)IBA
11/2009
1Interleukin-2 (IL2)IBA
11/2009
1Interleukin-1 (Interleukin 1)IBA
06/2009
1Histocompatibility Antigens Class IIBA
04/2008
1Cystine (L-Cystine)IBA
04/2008
1EpitopesIBA
04/2008
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
12/2006

Therapy/Procedure

15Therapeutics
03/2024 - 01/2006
4Immunotherapy
03/2024 - 01/2021
2Drug Therapy (Chemotherapy)
06/2013 - 12/2006
1Immunomodulation
10/2023